The human microbiome is the collection of microbes that colonize the human body. The Genome Institute is applying next generation sequencing technology to analyze the genomes of these organisms and characterize the communities they form in healthy and diseased individuals. This research could ultimately provide doctors with new diagnostic and therapeutic approaches for a number of diseases.
The Genome Institute is using comparative metagenomics to study the human microbiome, the collection of microbes that colonize the human body. We are focusing on the development of new and existing computational tools that will enable reliable structural and functional characterization of microbial systems and communities. This work will lead to a deeper understanding of how these organisms influence human physiology, nutrition, immunity and development.
The Genome Institute is collaborating with researchers in the Gambia to understand what makes a type of bacteria that causes pneumonia so deadly and how its vaccine affects the microbial populations that colonize infants.
The International Human Microbiome Congress (IHMC) is a yearly meeting where researchers from around the world gather to discuss the human microbiome, the complement of microbes that are present in the body, and its role in human health and disease.
A precursor to the Human Microbiome Project, the Human Gut Microbiome project seeks to deliver a more comprehensive view of our biology by providing deep draft whole genome sequences for 100 species representing the bacterial divisions known to reside in the distal gut.
This project is studying the gut microbial populations of vervet monkeys from the Wake Forest University Primate Center Vervet Research Colony.